Sunday, August 17, 2025
  • Advertise
  • Recruitment
  • Contact us:
  • Register
Irish Pharmacy News
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
  • News
    • Latest
    • Community Pharmacy
  • Learning
    • CPD
    • Features
    • Team Training
    • Research
  • Magazines
  • OTC
    • OTC Awards
    • Product News
  • Awards
    • Irish Pharmacy Awards 2024
    • Awards News
  • HPN
  • Log In
  • Register
No Result
View All Result
Irish Pharmacy News

Clonmel Healthcare offers Ireland’s Pharmacies a broader portfolio

Robyn Maginnis by Robyn Maginnis
23 December 2021
in Uncategorised
0
Clonmel Healthcare offers Ireland’s Pharmacies a broader portfolio

Repro Free: Pictured at the official opening of Clonmel Healthcare’s brand new 2 million euro warehouse facility in Clonmel is CEO Jim Hanlon. Picture Andres Poveda

  • Addition of the Pharmaton vitality/immunity range strengthens Clonmel Healthcare’s offering as the go-to-partner for Irish pharmacies this winter.
  • Clonmel Healthcare is responsible for the marketing and sales of Sanofi’s consumer healthcare range of products in the Irish market. These include their allergy medicines; Telfast, Nasacort and Opticrom, and the Dulcolax laxative range, Buscopan for IBS, and Maalox antacids. These form part of a wider agreement covering 20 countries.
  • Jim Hanlon, Clonmel Healthcare’s General Manager: “The addition of such brands significantly strengthens Clonmel’s position as a trusted partner to pharmacists, patients and consumers throughout the country”. 

Clonmel Healthcare Ireland December 2021 – Clonmel Healthcare is now offering pharmacists, and their customers, a broader range of consumer healthcare brands. Like Pharmaton vitality/immunity, Telfast, Nasacort, Opticrom, and the Dulcolax laxative range, as well as Buscopan for IBS, and Maalox antacids. These attractive brands are covered by an agreement whereby Clonmel’s parent group STADA, is distributing and marketing Sanofi’s local portfolio of well-established consumer healthcare products across 20 countries.

The addition of such well known and strong brands like Pharmaton will enhance Clonmel’s existing portfolio of winter products, including the companies recently launched Medithyme cough syrup and long established Paralief (Paracetamol) and Easofen (Ibuprofen) ranges.With Clonmel Healthcare as a trusted partner, Irish pharmacists can be sure they are offering their customers an appealing and comprehensive offering for a range of symptoms.

“The addition of Sanofi’s portfolio to Clonmel Healthcare’s current offering will alter the companies ranked position in the market to No. 2 by volume, and will firmly place the company in the top 5 OTC companies in Ireland” according to Jim Hanlon, General Manager at Clonmel Healthcare. He further added “Adding major brands like Buscopan and Dioralyte for rehydration further strengthens the companies’ position. We look forward to supporting pharmacy purchases with targeted and effective promotional campaigns for these brands.

Other brands in Clonmel Healthcare’s new offering included Antihistan Cream (Mepyramine Maleate) and Selsun anti-dandruff shampoo. These join Clonmel’s other products in the anti-fungal head care treatments such as Nizoral Shampoo.  

Previous Post

Free Period Products for young people offered by the Sexual Health Centre

Next Post

Longevity and the 100 Year Life

Next Post
an older couple

Longevity and the 100 Year Life

Leave a Reply

Your email address will not be published. Required fields are marked *

Supporting Enhanced Price Transparency in Pharmacies

Supporting Enhanced Price Transparency in Pharmacies

13 August 2025
Has women’s health in Ireland improved? Category Report: Women’s Health

Has women’s health in Ireland improved? Category Report: Women’s Health

13 August 2025
RCSI programme reaches over 17,000 Irish teens combating sexual health misinformation

RCSI programme reaches over 17,000 Irish teens combating sexual health misinformation

12 August 2025

RECOMMENDED NEWS

New €9.75m Irish-Led Project Set to Strengthen EU Preparedness and Response to Future Pandemics

New €9.75m Irish-Led Project Set to Strengthen EU Preparedness and Response to Future Pandemics

5 years ago
Recommending Supplements for Infants and Young Children

Recommending Supplements for Infants and Young Children

3 years ago

Taoiseach and Ministers for Health announce €450K funding boost to HIV

6 years ago

Minister for Health launches public consultation on access to contraception

6 years ago
Tweets by Irish_PharmNews

Quick links

  • About
  • Advertise
  • Careers
  • Contact us

Other info

  • Contact us
  • Register for Digital Magazines
  • Privacy Policy
  • About
  • Advertise
  • Careers
  • Contact us

© 2024 IPN

  • Login

    Forgot password? | Register

    Register

    Registration confirmation will be emailed to you.

    Login | Forgot password?

    Reset Password

    Please enter your username or email address. You will receive a link to create a new password via email.

    Login

Login

Register

Forgotten Password?

Register | Lost your password?
| Back to Login
No Result
View All Result
  • News
  • Learning
  • Other
    • Conferencing
    • Developments
    • Product News
    • Profiles
    • Research
  • Digital Magazines (IPN Online Issues Older Issue Tabs)
  • Awards

© 2024 IPN